Close

Anti-NES DNA-encoded mAb (DMAb), pVAX1 (DMAb-1363-WJ)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-NES DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • NES
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-1366-WJ 10C2 Mouse Human IgG1, κ A fragment of the human Nestin protein corresponding to residues 1464-1614.
DMAb-1368-WJ 2C1.3A11 Mouse Human IgG1
DMAb-1381-WJ 1A9G12 Mouse Human IgG1
DMAb-1381-WJ 1A9G12 Mouse Human IgG2b Purified recombinant fragment of human NES (amino acids: 419-588 ) expressed in E. Coli
DMAb-1381-WJ 1A9G12 Mouse Human IgM Purified recombinant fragment of human NESTIN (AA: 419-588 ) expressed in E. Coli
DMAb-0018-CN 1B4 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 99-349 of human NES(NP_006608) produced in E.coli
DMAb-1385-WJ 1D11H2 Mouse IgG2b
DMAb-1388-WJ 3k1 Mouse Human IgG1 NS0 cells transfected with human Nestin. Uni.
DMAb-1168-WJ 4D11 Mouse IgG1 A preparation of a segment of recombinant human Nestin (amino acids 317 to 630) expressed in bacteria and highly purified
DMAb-0734-YY 4D4 Mouse IgG
DMAb-1391-WJ 5C93 Mouse Human IgG1 Synthetic peptide corresponding to 150aa fragment from human nestin conjugated to glutathione S-transferase
DMAb-689-YC 7A3 Rat Mouse IgG2b
DMAb-1393-WJ 9A19 Mouse Human IgG1, κ Recognizes human nestin. It does not crossreact with rodent protein
DMAb-1395-WJ GT623 Mouse IgG1 Recombinant protein encompassing a sequence within the C-terminus region of human Nestin. The exact sequence is proprietary

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-NES DNA-encoded mAb (DMAb), pVAX1 (DMAb-1363-WJ). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.